Inverse agonists and neutral antagonists for the TSH receptor

Details for Australian Patent Application No. 2011237421 (hide)

Owner THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

Inventors Gershengorn, Marvin; Neumann, Susanne; Huang, Wenwei; Thomas, Craig J.

Agent Griffith Hack

Pub. Number AU-A-2011237421

PCT Pub. Number WO2011/127388

Priority 61/322,138 08.04.10 US

Filing date 8 April 2011

Wipo publication date 13 October 2011

International Classifications

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 Antineoplastic agents

C07D 239/91 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/127388 Priority application(s): WO2011/127388

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237440-Use of Ti and Nb cemented TiC in prosthetic joints

2011237393-B-cell antigen presenting cell assay